Bridgeway Capital Management’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.97K | Sell |
|
|||||
|
2024
Q2 | $33.1K | Sell |
|
|||||
|
2024
Q1 | $51.3K | Hold |
|
|||||
|
2023
Q4 | $47.9K | Hold |
|
|||||
|
2023
Q3 | $49.5K | Hold |
|
|||||
|
2023
Q2 | $73K | Hold |
|
|||||
|
2023
Q1 | $46.8K | Sell |
|
|||||
|
2022
Q4 | $47.1K | Hold |
|
|||||
|
2022
Q3 | $88K | Hold |
|
|||||
|
2022
Q2 | $118K | Sell |
|
|||||
|
2022
Q1 | $171K | Sell |
|
|||||
|
2021
Q4 | $199K | Sell |
|
|||||
|
2021
Q3 | $477K | Sell |
|
|||||
|
2021
Q2 | $529K | Sell |
|
|||||
|
2021
Q1 | $615K | Buy |
|
|||||
|
2020
Q4 | $199K | Buy |
|